Literature DB >> 33723812

Key Steps Toward a Promotional Communications Strategy: Collaboration Best Practices for Teams Creating Promotional Materials and Regulatory Colleagues.

Mary L Raber-Johnson1, Mark Stinson2, Carlotta Dillon3, George J Wan4.   

Abstract

A promotional communications strategy is considered early in prescription medical product development by commercial disciplines (e.g., commercial/marketing) and informs promotional materials to key stakeholders such as healthcare providers and patients. Health economics and outcomes research (HEOR) is a scientific discipline that is also responsible for the generation of promotional materials to other key stakeholders such as payors. The overarching promotional strategy benefits from consistent partnerships with regulatory affairs colleagues, culminating in cost savings and patient-centric promotional materials. Yet there is a paucity of published content that details effective collaboration between promotional teams and regulatory colleagues prior to medical/legal/regulatory (MLR) review. The following review aims to showcase such organizational innovation from the perspective of teams developing promotional materials (i.e., commercial and HEOR). Behind-the-scenes marketing activities are described in relation to the following key steps that build the strategy's foundation: insight gathering from key stakeholders; sub-strategy development; tactic identification; and promotional message development. Integration of regulatory colleagues with teams developing promotional materials is imperative to accomplish these key steps prior to any MLR review. Finally, four themes in best practices for collaboration with regulatory colleagues are shared from the perspective of commercial disciplines and HEOR, alongside a real-world example for each: (1) Alignment of Strategies; (2) Shared Process & Tools; (3) Creative Problem-Solving; and (4) Culture of Connecting.

Entities:  

Year:  2021        PMID: 33723812     DOI: 10.1007/s43441-021-00272-1

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  4 in total

1.  Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap.

Authors:  Jan Geissler; Bettina Ryll; Susanna Leto di Priolo; Mary Uhlenhopp
Journal:  Ther Innov Regul Sci       Date:  2017-05-08       Impact factor: 1.778

Review 2.  Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances.

Authors:  Mary L Raber-Johnson; Wolfgang E Gallwitz; Eugene J Sullivan; Philip Storer
Journal:  Ther Innov Regul Sci       Date:  2020-01-06       Impact factor: 1.778

3.  Disease Information in Direct-to-Consumer Prescription Drug Print Ads.

Authors:  Kathryn J Aikin; Helen W Sullivan; Kevin R Betts
Journal:  J Health Commun       Date:  2015-12-30

4.  An Evolved Approach to Advisory Boards in Rare Disease Drug Development: 5-Step Model to Finding and Engaging Patient Advisors.

Authors:  Carlotta Dillon; Joyce Knapp; Mark Stinson
Journal:  J Patient Exp       Date:  2020-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.